Defence Therapeutics Inc (DTC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,321 | 1,232 | 2,080 | 131 | 131 |
| Receivables | 222 | 198 | 88 | 46 | 33 |
| TOTAL | $2,576 | $1,464 | $2,172 | $193 | $197 |
| Non-Current Assets | |||||
| PPE Net | 193 | 188 | 192 | 210 | 227 |
| TOTAL | $193 | $188 | $192 | $210 | $227 |
| Total Assets | $2,769 | $1,652 | $2,364 | $403 | $425 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,558 | N/A | 1,377 | 1,261 | 1,812 |
| TOTAL | $2,763 | $1,418 | $2,583 | $3,857 | $4,546 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 1,489 | N/A | N/A | N/A |
| TOTAL | $1,413 | $1,489 | $0 | $0 | $0 |
| Total Liabilities | $4,176 | $2,907 | $2,583 | $3,857 | $4,546 |
| Shareholders' Equity | |||||
| Common Shares | 24,191 | 24,191 | 19,929 | 20,245 | 19,242 |
| Retained earnings | -30,016 | -29,306 | -28,314 | -28,072 | -30,384 |
| Other shareholders' equity | 4,417 | 3,859 | 8,165 | 4,374 | 7,020 |
| TOTAL | $-1,407 | $-1,256 | $-220 | $-3,454 | $-4,121 |
| Total Liabilities And Equity | $2,769 | $1,652 | $2,364 | $403 | $425 |